<--- Back to Details
First PageDocument Content
Osteopathies / Bisphosphonate / Anatomy / Osteonecrosis of the jaw / Osteoporosis / Alendronic acid / Risedronic acid / Mylanta / Teriparatide / Bisphosphonates / Medicine / Health
Date: 2013-08-02 01:08:20
Osteopathies
Bisphosphonate
Anatomy
Osteonecrosis of the jaw
Osteoporosis
Alendronic acid
Risedronic acid
Mylanta
Teriparatide
Bisphosphonates
Medicine
Health

PATIENT INFORMATION ON BISPHOSPHONATES (TABLETS) (Examples of brand names: for alendronate - Adronat, Alendrobell, Alendro, Fosamax, Fosamax Plus, Fosamax D, Ossmax; for risedronate – Acris Once-a-Week, Actonel, Actone

Add to Reading List

Source URL: www.rheumatology.org.au

Download Document from Source Website

File Size: 212,15 KB

Share Document on Facebook

Similar Documents

www.edoriumjournals.com  CASE SERIES PEER REVIEWED | OPEN ACCESS

www.edoriumjournals.com CASE SERIES PEER REVIEWED | OPEN ACCESS

DocID: 1rkMG - View Document

Grünenthal has promoted it as soon as you remember fosamax price philippines. The first call she made was to her brother, who raced over to pick from a qualified practitioner. In 1959, phentermine first received approva

Grünenthal has promoted it as soon as you remember fosamax price philippines. The first call she made was to her brother, who raced over to pick from a qualified practitioner. In 1959, phentermine first received approva

DocID: 1r1Vx - View Document

OF THE  A Professional Guide for the Management of Patients Undergoing Chemotherapy and Head and Neck Radiation Therapy

OF THE A Professional Guide for the Management of Patients Undergoing Chemotherapy and Head and Neck Radiation Therapy

DocID: 1qXFO - View Document

Losing weight and keeping it off if i continue doing what i am going to alendronate tablets teva experience fewer problems compared to placebo-treated patients. Note: Any medical information published on this web site is

Losing weight and keeping it off if i continue doing what i am going to alendronate tablets teva experience fewer problems compared to placebo-treated patients. Note: Any medical information published on this web site is

DocID: 1qRg1 - View Document

www.edoriumjournals.com  Case report	PEER REVIEWED | OPEN ACCESS Recurrent osteosarcoma of maxilla presenting as fungating mass: A case report

www.edoriumjournals.com Case report PEER REVIEWED | OPEN ACCESS Recurrent osteosarcoma of maxilla presenting as fungating mass: A case report

DocID: 1qJNd - View Document